References
<A NAME="RD17602ST-1A">1a</A>
Vacca JP.
Condra JH.
Drug Discovery Today
1997,
2:
261
<A NAME="RD17602ST-1B">1b</A>
Steele FR.
Nature Med.
1996,
2:
257
<A NAME="RD17602ST-2">2</A>
Wlodawer A.
Vondrasek J.
Annu. Rev. Biophys. Biomol. Struct.
1998,
27:
249
<A NAME="RD17602ST-3">3</A>
Babine RE.
Bender SL.
Chem. Rev.
1997,
97:
1359
<A NAME="RD17602ST-4">4</A>
Tomasselli AG.
Heinrikson RL.
Biochim. Biophys.
Acta
2000,
189
<A NAME="RD17602ST-5">5</A> For comparative quantitative structure-activity
relationship studies on anti-HIV drugs, see:
Garg R.
Gupta SP.
Gao H.
Babu MS.
Debnath AK.
Hansch C.
Chem. Rev.
1999,
99:
3525
<A NAME="RD17602ST-6">6</A>
Lyle TA.
Wiscount CM.
Guare JP.
Thompson WJ.
Anderson PS.
Darke PL.
Zugay JA.
Emini EA.
Schleif WA.
Quintero JC.
Dixion RAF.
Sigal IS.
Huff JR.
J.
Med. Chem.
1991,
34:
1228
<A NAME="RD17602ST-7">7</A>
Panchagnula R.
Thomas NS.
Int. J. Pharm.
2000,
201:
131
For the synthesis of analogues of
L-685,434, see:
<A NAME="RD17602ST-8A">8a</A>
Litera J.
Budesinsky M.
Urban J.
Soucek M.
Collect. Czech. Chem. Commun.
1998,
63:
231
<A NAME="RD17602ST-8B">8b</A>
Litera J.
Weber J.
Krizova I.
Pichova I.
Konvaluka J.
Fusek M.
Soucek M.
Collect.
Czech. Chem. Commun.
1998,
63:
541
<A NAME="RD17602ST-8C">8c</A>
Evans BE.
Rittle KE.
Homnick CF.
Springer JP.
Hirshfield J.
Veber DF.
J.
Org. Chem.
1985,
50:
4615
<A NAME="RD17602ST-9A">9a</A>
cis-Lactone 11 is
also an important intermediate for the synthesis of potent HIV-1
protease inhibitors:
Ghosh AK.
McKee SP.
Thompson WJ.
Darke PL.
Zugay JC.
J. Org. Chem.
1993,
58:
1025
<A NAME="RD17602ST-9B">9b</A>
Thompson WJ.
Fitzgerald PMD.
Holloway MK.
Emini EA.
Darke PL.
McKeever BM.
Schleif WA.
Quintero JC.
Zugay JA.
Tucker TJ.
Schwering JE.
Homnick CF.
Nunberg J.
Springer JP.
Huff JR.
J. Med. Chem.
1992,
35:
1685
<A NAME="RD17602ST-10">10</A> For synthesis of analogues of L-682,679,
see:
deSolms SJ.
Giuliani EA.
Guare JP.
Vacca JP.
Sanders WM.
Graham SL.
Wiggins JM.
Darke PL.
Sigal IS.
Zugay JA.
Emini EA.
Schleif WA.
Quintero JC.
Anderson PS.
Huff JR.
J.
Med. Chem.
1991,
34:
2852
<A NAME="RD17602ST-11">11</A>
Evans J.
Chem.
Brit.
2001,
April:
47
<A NAME="RD17602ST-12">12</A>
Pesti JA.
Chorvat RJ.
Huhn GF.
Chem. Innovation
2000,
October:
29
<A NAME="RD17602ST-13">13</A>
de Clerq E.
Pure
Appl. Chem.
2001,
73:
55
<A NAME="RD17602ST-14">14</A>
Ghosh AK.
Shin D.
Mathivanan P.
Chem.
Commun.
1999,
1025
<A NAME="RD17602ST-15">15</A>
Li YM.
Xu M.
Lai MT.
Huang Q.
Castro JL.
DiMuzio-Mower J.
Harrison T.
Lellis C.
Nadin A.
Neduvelil JG.
Register RB.
Sardana MK.
Shearman MS.
Smith AL.
Shi XP.
Yin KC.
Shafer JA.
Gardell SJ.
Nature (London)
2000,
405:
689
<A NAME="RD17602ST-16">16</A>
Li YM.
Lai MT.
Xu M.
Huang Q.
DiMuzio-Mower J.
Sardana MK.
Shi XP.
Yin KC.
Shafer JA.
Gardell SJ.
Proc. Natl. Acad.
Sci. U.S.A.
2000,
97:
6138
<A NAME="RD17602ST-17">17</A>
Shearman MS.
Beher D.
Clarke EE.
Lewis HD.
Harrison T.
Hunt P.
Nadin A.
Smith AL.
Stevenson G.
Castro JL.
Biochemistry
2000,
39:
8698
<A NAME="RD17602ST-18">18</A>
Nadin A.
López JMS.
Neduvelil JG.
Thomas SR.
Tetrahedron
2001,
57:
1861
<A NAME="RD17602ST-19">19</A>
Dias LC.
Giacomini R.
J. Braz. Chem. Soc.
1998,
9:
357
<A NAME="RD17602ST-20">20</A>
Dias LC.
Giacomini R.
Tetrahedron Lett.
1998,
39:
5343
<A NAME="RD17602ST-21">21</A>
Dias LC.
Meira PRR.
Ferreira E.
Org. Lett.
1999,
1:
1335
<A NAME="RD17602ST-22">22</A>
Dias LC.
Meira PRR.
Synlett
2000,
37
<A NAME="RD17602ST-23">23</A>
Dias LC.
Ferreira E.
Tetrahedron Lett.
2001,
42:
7159
<A NAME="RD17602ST-24A">24a</A>
Fehrentz JA.
Castro B.
Synthesis
1983,
676
<A NAME="RD17602ST-24B">24b</A>
Saari WS.
Fisher TE.
Synthesis
1990,
453
For optical stability studies of N-protected α-amino aldehydes,
see:
<A NAME="RD17602ST-25A">25a</A>
Jurczak J.
Golebiowski A.
Chem. Rev.
1989,
89:
149
<A NAME="RD17602ST-25B">25b</A>
Myers AG.
Zhong BY.
Movassaghi M.
Kung DW.
Lanman BA.
Kwon S.
Tetrahedron Lett.
2000,
41:
1359
<A NAME="RD17602ST-26">26</A>
Benedetti F.
Miertus S.
Norbedo S.
Tossi A.
Zlatoidzky P.
J.
Org. Chem.
1997,
62:
9348
<A NAME="RD17602ST-27A">27a</A>
D’Aniello F.
Mann A.
Mattii D.
Taddei M.
J.
Org. Chem.
1994,
59:
3762
<A NAME="RD17602ST-27B">27b</A>
Ciapetti P.
Falorni M.
Taddei M.
Tetrahedron
1996,
52:
7379
<A NAME="RD17602ST-28">28</A>
Ley SV.
Norman J.
Griffith WP.
Marsden SP.
Synthesis
1994,
639
For other synthesis of these lactones,
see:
<A NAME="RD17602ST-29A">29a</A>
Ghosh AK.
Fidanze S.
J. Org.
Chem.
1998,
63:
6146
<A NAME="RD17602ST-29B">29b</A>
Pégorier L.
Larchevêque M.
Tetrahedron
Lett.
1995,
36:
2753 ;
see also ref. 9a
<A NAME="RD17602ST-30A">30a</A>
Dess DB.
Martin JC.
J.
Am. Chem. Soc.
1991,
113:
7277
<A NAME="RD17602ST-30B">30b</A>
Ireland RE.
Liu L.
J. Org. Chem.
1993,
58:
2899
<A NAME="RD17602ST-31">31</A>
Hoffman RV.
Maslouch N.
Cervantes-Lee F.
J.
Org. Chem.
2002,
67:
1045
<A NAME="RD17602ST-32">32</A>
New compounds and the additional isolatable
intermediates gave satisfactory 1H and 13C
NMR, IR, HRMS and analytical data. Yields refer to chromatographically
and spectroscopically homogeneous materials.
<A NAME="RD17602ST-33">33</A>
L-685,434(1): N
-[(2
R
)-Hydroxy-(1
S
)-indanyl]-(5
S
)-{[
tert
-butoxycarbonyl]-amino-(4
S
)-hydroxy-6-phenyl-(2
R
)-benzyl}-hexanamide: IR
(KBr) 3447, 3365, 3061, 3022, 2917, 2849, 1665, 1645, 1537, 1392,
1278, 1158, 1058, 899, 862, 733, 703, 649 cm-1. 1H
NMR (500 MHz, DMSO): δ = 1.37 (s, 9 H), 1.80-1.96
(m, 2 H), 2.72-2.95 (m, 6 H), 3.02 (dd, J = 5.1,
16.8 Hz, 1 H), 3.45 (m, 1 H), 3.68 (m, 1 H), 3.81 (m, 1 H), 4.22
(t, J = 4.8 Hz, 1 H), 4.81 (d, J = 9.5 Hz, 1 H), 5.23 (dd, J = 6.1, 8.4 Hz, 1 H), 5.87
(d, J = 8.4 Hz, 1 H), 7.05 (brs,
1 H), 7.05-7.30 (m, 14 H). 13C
NMR (125 MHz, DMSO): δ = 28.5, 37.5, 39.0, 39.1,
39.6, 47.1, 57.4, 57.6, 69.3, 73.1, 79.6, 124.1, 125.1, 126.4, 126.5,
127.0, 128.0, 128.4, 128.5, 129.0, 129.3, 138.4, 139.8, 140.1, 140.3,
156.2, 175.4. TLC: Rf = 0.21 (60% EtOAc:hexanes).
L-682,679(2): {(1
S
)-benzyl-4
R
-[1-((1
S
)-carbamoyl-2-phenyl-ethylcarbamoyl)-(1
S
)-3-methyl-butyl-carbamoyl]-(2
S
)-hydroxy-5-phenyl-pentyl} Carbamic Acid tert
-Butyl Ester: IR
(KBr) 3377, 3341, 3190, 2955, 2924, 2872, 2853, 1667, 1649, 1621,
1531, 1451, 1365, 1273, 1250, 1172, 1080, 743, 698 cm-1. 1H
NMR (500 MHz, DMSO): δ = 0.77 (d, J = 6.4 Hz, 3 H), 0.84 (d, J = 6.4 Hz,
3 H), 1.28
(s, 9 H), 1.20-1.35 (m, 2 H), 1.49 (m, 1 H), 1.60 (m, 2
H), 2.45 (dd, J = 8.2, 13.4
Hz, 1 H), 2.53 (dd, J = 9.5, 13.7
Hz, 1 H), 2.70 (dd, J = 5.0,
13.6 Hz, 1 H), 2.78-2.87 (m, 3 H), 3.00 (dd, J = 5.2, 3.7 Hz, 1 H), 3.51-3.57
(m, 1 H), 4.21 (q, J = 6.7 Hz,
1 H), 4.42 (q, J = 5.5 Hz, 1
H), 4.48 (d, J = 6.1 Hz, 1 H),
6.36 (d, J = 9.0 Hz, 1 H), 7.09
(brs, 1 H), 7.12-7.25 (m, 15 H), 7.34 (brs, 1 H), 7.70
(d, J = 8.0 Hz, 1 H), 7.93 (d, J = 8.0 Hz, 1 H). 13C
NMR (125 MHz, DMSO): δ = 23.1, 24.2, 28.0, 28.4,
35.1, 36.3, 37.7, 38.9, 40.9, 43.7, 51.5, 53.5, 56.5, 69.4, 77.6,
125.9, 126.0, 126.4, 128.1, 128.2, 128.3, 129.1, 129.2, 129.4, 137.9,
139.8, 140.0, 155.5, 171.8, 172.8, 174.7. TLC: Rf = 0.18
(70% EtOAc:hexanes).
L-685,458(3): {(1
S
)-benzyl-(4
R
)-[1-((1
S
)-carbamoyl-2-phenyl-ethylcarbamoyl)-(1
S
)-3-methyl-butyl-carba-moyl]-(2
R
)-hydroxy-5-phenyl-pentyl} Carbamic
Acid tert
-Butyl
Ester: White solid. Mp 212-213 °C. [α]D
25 =
-26.8
(c 0.5, CHCl3). IR (KBr):
3375, 3338, 3197, 2960, 2930, 2872, 2856, 1666, 1647, 16231, 1535,
1451, 13675, 1271, 1251, 1174, 1086, 743, 698 cm-1. 1H
NMR (500 MHz, DMSO): δ = 0.74 (d, J = 6.6 Hz, 3 H), 0.81 (d, J = 6.6 Hz,
3 H), 1.24
(s, 9 H), 1.25-1.40 (m, 2 H), 144-1.70 (m, 3 H), 2.40-3.00
(m, 7 H), 3.42 (m, 2 H), 4.16 (m, 1 H), 4.40 (m,
1 H),
4.70 (brs, 1 H), 6.48 (d, J = 9.0
Hz, 1 H), 7.05-7.27
(m, 17 H), 7.62 (d, J = 8.1 Hz, 1 H), 7.87 (d, J = 7.8 Hz, 1 H). 13C
NMR (125 MHz, DMSO): δ = 23.9, 25.4, 26.1, 30.4, 37.6,
38.0, 39.8, 39.9, 42.8, 46.6, 53.7, 55.8, 58.9, 73.5, 79.7, 127.9,
128.0, 128.6, 130.0, 130.2, 130.4, 131.1, 131.4, 140.0, 142.0, 142.3,
157.4, 174.0, 174.8, 175.2. TLC:
Rf = 0.21
(60% EtOAc:hexanes).